Cargando…

Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection

The ultimate goal of pegylated interferon-alfa-2a (Peg-IFN-α) therapy in chronic hepatitis B (CHB) infection is HBsAg seroconversion. Even though B cells are major mediators of a positive clinical outcome, their modulation during Peg-IFN-α therapy has not yet been described. We investigated here the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aspord, Caroline, Bruder Costa, Juliana, Jacob, Marie-Christine, Dufeu-Duchesne, Tania, Bertucci, Inga, Pouget, Noelle, Brevot-Lutton, Ophelie, Zoulim, Fabien, Bourliere, Marc, Plumas, Joel, Leroy, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900671/ https://www.ncbi.nlm.nih.gov/pubmed/27281019 http://dx.doi.org/10.1371/journal.pone.0156200

Ejemplares similares

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion
por: Bruder Costa, Juliana, et al.
Publicado: (2016)

Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs
por: Ouaguia, Laurissa, et al.
Publicado: (2020)

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
por: Ouaguia, Laurissa, et al.
Publicado: (2019)

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression
por: Aspord, Caroline, et al.
Publicado: (2014)

Pharmacokinetic Parameters of Oral Pegylated IFN-λ1
por: Sherstoboev, E. Yu., et al.
Publicado: (2022)

Antiproliferative effects of sorafenib and pegylated IFN-α2b on human liver cancer cells in vitro and in vivo
por: KUSANO, HIRONORI, et al.
Publicado: (2013)

Use of Protein Pegylation to Prolong the Antiviral Effect of IFN Against FMDV
por: Diaz-San Segundo, Fayna, et al.
Publicado: (2021)

Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2023)

Innate Antiviral Immune Responses to Hepatitis B Virus
por: Ait-goughoulte, Malika, et al.
Publicado: (2010)

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection
por: Revill, Peter A., et al.
Publicado: (2019)

The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α
por: Wu, Ze-Qian, et al.
Publicado: (2021)

HBVdb: a knowledge database for Hepatitis B Virus
por: Hayer, Juliette, et al.
Publicado: (2013)

The reduction in CD8(+)PD-1(+) T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients
por: Liu, Ruyu, et al.
Publicado: (2020)

A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells
por: Aspord, Caroline, et al.
Publicado: (2010)

Clonal relationships of memory B cell subsets in autoimmune mice
por: Aranburu, Alaitz, et al.
Publicado: (2023)

Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets
por: Bradford, Hannah F., et al.
Publicado: (2023)

ZNF395 Is an Activator of a Subset of IFN-Stimulated Genes
por: Schroeder, Linda, et al.
Publicado: (2017)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

B Cell Subsets in Atherosclerosis
por: Perry, Heather M., et al.
Publicado: (2012)

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
por: Lin, Yanjie, et al.
Publicado: (2023)

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

GlycoPEGylated recombinant factor IX for hemophilia B in context
por: Santagostino, Elena, et al.
Publicado: (2018)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
por: Vasconcelos, Joana, et al.
Publicado: (2022)

A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection
por: Zoulim, Fabien, et al.
Publicado: (2018)

The Hepatitis B Virus Genotypes E to J: The Overlooked Genotypes
por: Toyé, Rayana Maryse, et al.
Publicado: (2023)

Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection
por: Boettler, Tobias, et al.
Publicado: (2022)

Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
por: Groves, M D, et al.
Publicado: (2009)

Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
por: Zheng, Caixia, et al.
Publicado: (2019)

Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study
por: Chevaliez, Stéphane, et al.
Publicado: (2022)

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
por: Sandoughdaran, Saleh, et al.
Publicado: (2015)

PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo
por: Hočevar, Sandra, et al.
Publicado: (2022)

A unique B2 B cell subset in the intestine
por: Shimomura, Yasuyo, et al.
Publicado: (2008)

Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints
por: Girard, Pauline, et al.
Publicado: (2020)

Functions of Liver Natural Killer Cells Are Dependent on the Severity of Liver Inflammation and Fibrosis in Chronic Hepatitis C
por: Fugier, Emilie, et al.
Publicado: (2014)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
por: Oke, Vilija, et al.
Publicado: (2017)

Dysregulation of IFN System Can Lead to Poor Response to Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis C
por: Onomoto, Koji, et al.
Publicado: (2011)

Contribution of NK cells to HBsAg seroconversion in inactive HBsAg carriers following pegylated IFN therapy
por: Cao, Zhenhuan, et al.
Publicado: (2020)

New anti-HCV agents in the pipeline
por: Zoulim, Fabien
Publicado: (2014)

Landscape of oncoviral genotype and co-infection via human papilloma and hepatitis B viral tumor in situ profiling
por: Bubie, Adrian, et al.
Publicado: (2021)

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_79obm52vth9hfaoq8govbv4nsi